The impacts of ribociclib on the post-treatment Tp-e interval and Tp-e/QTc ratio in breast cancer patients

Advances in Medical Sciences · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles